(-)-demecolcine increases expression ISO KCNJ2 (Homo sapiens) 6480464 Demecolcine results in increased expression of KCNJ2 mRNA CTD PMID:23649840 1-chloro-2,4-dinitrobenzene decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Dinitrochlorobenzene results in decreased expression of KCNJ2 mRNA CTD PMID:17374397 15-acetyldeoxynivalenol increases expression ISO KCNJ2 (Homo sapiens) 6480464 15-acetyldeoxynivalenol results in increased expression of KCNJ2 mRNA CTD PMID:23792671 17beta-estradiol multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of KCNJ2 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO KCNJ2 (Homo sapiens) 6480464 Estradiol results in increased expression of KCNJ2 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of KCNJ2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KCNJ2 mRNA CTD PMID:26377647 2-palmitoylglycerol increases expression ISO KCNJ2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of KCNJ2 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Kcnj2 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3,4-dichloroaniline decreases expression ISO KCNJ2 (Homo sapiens) 6480464 3 and 4-dichloroaniline results in decreased expression of KCNJ2 mRNA CTD PMID:24172598 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of KCNJ2 mRNA CTD PMID:20188158 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Oxazolone results in decreased expression of KCNJ2 mRNA CTD PMID:17374397 5-aza-2'-deoxycytidine decreases expression EXP 6480464 Decitabine results in decreased expression of KCNJ2 mRNA CTD PMID:27915011 acetamide increases expression ISO Kcnj2 (Rattus norvegicus) 6480464 acetamide results in increased expression of KCNJ2 mRNA CTD PMID:31881176 all-trans-retinoic acid increases expression ISO KCNJ2 (Homo sapiens) 6480464 Tretinoin results in increased expression of KCNJ2 mRNA CTD PMID:21934132 all-trans-retinoic acid affects expression ISO KCNJ2 (Homo sapiens) 6480464 Tretinoin affects the expression of KCNJ2 mRNA CTD PMID:34742744 all-trans-retinoic acid decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of KCNJ2 mRNA CTD PMID:23724009 amiodarone increases expression ISO KCNJ2 (Homo sapiens) 6480464 Amiodarone results in increased expression of KCNJ2 mRNA CTD PMID:19774075 ammonium chloride affects expression ISO Kcnj2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of KCNJ2 mRNA CTD PMID:16483693 arsane decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Arsenic results in decreased expression of KCNJ2 mRNA CTD PMID:16835338 arsenic atom decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Arsenic results in decreased expression of KCNJ2 mRNA CTD PMID:16835338 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of KCNJ2 mRNA CTD PMID:33053406 atenolol affects response to substance ISO KCNJ2 (Homo sapiens) 6480464 KCNJ2 gene affects the susceptibility to Atenolol CTD PMID:15028050 barium chloride multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 barium chloride inhibits the reaction [KCNJ2 protein results in increased transport of Potassium] CTD PMID:11087224 barium(0) multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 Barium inhibits the reaction [KCNJ2 protein results in increased transport of Potassium] CTD PMID:15958527 and PMID:17347781 barium(0) decreases activity EXP 6480464 Barium results in decreased activity of KCNJ2 protein CTD PMID:17699636 barium(0) decreases activity ISO KCNJ2 (Homo sapiens) 6480464 Barium results in decreased activity of KCNJ2 protein CTD PMID:12598232 belinostat decreases expression ISO KCNJ2 (Homo sapiens) 6480464 belinostat results in decreased expression of KCNJ2 mRNA CTD PMID:27188386 benzene affects expression ISO KCNJ2 (Homo sapiens) 6480464 Benzene affects the expression of KCNJ2 mRNA CTD PMID:21147609 benzo[a]pyrene increases expression ISO KCNJ2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of KCNJ2 mRNA CTD PMID:22316170 benzo[a]pyrene increases methylation ISO KCNJ2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of KCNJ2 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO KCNJ2 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate increases expression ISO Kcnj2 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of KCNJ2 mRNA CTD PMID:20920545 bis(2-ethylhexyl) phthalate increases expression ISO KCNJ2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of KCNJ2 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KCNJ2 promoter CTD PMID:23359474 bisphenol A multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KCNJ2 promoter CTD PMID:23359474 bisphenol A increases methylation ISO KCNJ2 (Homo sapiens) 6480464 bisphenol A results in increased methylation of KCNJ2 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KCNJ2 mRNA CTD PMID:30951980 bisphenol A increases expression ISO Kcnj2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of KCNJ2 mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A increases expression ISO KCNJ2 (Homo sapiens) 6480464 bisphenol A results in increased expression of KCNJ2 mRNA CTD PMID:29275510 bisphenol A decreases expression ISO Kcnj2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of KCNJ2 mRNA CTD PMID:25181051 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of KCNJ2 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KCNJ2 mRNA CTD PMID:29432896 cadmium dichloride decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of KCNJ2 mRNA CTD PMID:21457566 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of KCNJ2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KCNJ2 mRNA] CTD PMID:17585979 crocidolite asbestos increases expression ISO KCNJ2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of KCNJ2 mRNA CTD PMID:18687144 crocidolite asbestos decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of KCNJ2 mRNA CTD PMID:29523930 daunorubicin increases expression ISO KCNJ2 (Homo sapiens) 6480464 Daunorubicin results in increased expression of KCNJ2 mRNA CTD PMID:26537877 and PMID:28940058 diallyl disulfide multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 diallyl disulfide inhibits the reaction [tobacco tar analog results in decreased expression of KCNJ2 mRNA] CTD PMID:36758788 dibutyl phthalate multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KCNJ2 promoter CTD PMID:23359474 dioxygen increases expression ISO KCNJ2 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of KCNJ2 mRNA CTD PMID:24236059 dioxygen multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with SCH 442416] results in increased expression of KCNJ2 mRNA CTD PMID:24431311 diuron increases expression ISO KCNJ2 (Homo sapiens) 6480464 Diuron metabolite results in increased expression of KCNJ2 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO KCNJ2 (Homo sapiens) 6480464 Doxorubicin affects the expression of KCNJ2 mRNA CTD PMID:25529476 doxorubicin increases expression ISO KCNJ2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of KCNJ2 mRNA CTD PMID:26537877 more ... ethanol multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of KCNJ2 mRNA CTD PMID:29432896 ethyl methanesulfonate increases expression ISO KCNJ2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of KCNJ2 mRNA CTD PMID:23649840 eugenol decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Eugenol results in decreased expression of KCNJ2 mRNA CTD PMID:17374397 formaldehyde increases expression ISO KCNJ2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of KCNJ2 mRNA CTD PMID:23649840 fulvestrant decreases methylation ISO KCNJ2 (Homo sapiens) 6480464 Fulvestrant results in decreased methylation of KCNJ2 gene CTD PMID:31601247 halothane affects response to substance EXP 6480464 KCNJ2 affects the susceptibility to Halothane CTD PMID:17546530 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of KCNJ2 mRNA CTD PMID:26582142 methyl methanesulfonate increases expression ISO KCNJ2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of KCNJ2 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO KCNJ2 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of KCNJ2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO KCNJ2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of KCNJ2 mRNA CTD PMID:28001369 mitoxantrone increases expression ISO KCNJ2 (Homo sapiens) 6480464 Mitoxantrone results in increased expression of KCNJ2 mRNA CTD PMID:26537877 and PMID:28940058 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [TGFB1 protein results in decreased expression of KCNJ2 protein] CTD PMID:22853924 N-nitrosodiethylamine multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of KCNJ2 mRNA CTD PMID:20360939 nickel atom increases expression ISO KCNJ2 (Homo sapiens) 6480464 Nickel results in increased expression of KCNJ2 mRNA CTD PMID:23195993 nickel sulfate decreases expression ISO KCNJ2 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of KCNJ2 mRNA CTD PMID:16780908 and PMID:17374397 nitroprusside affects activity ISO Kcnj2 (Rattus norvegicus) 6480464 Nitroprusside affects the activity of KCNJ2 protein CTD PMID:14993195 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of KCNJ2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KCNJ2 mRNA] CTD PMID:17585979 paracetamol increases expression ISO Kcnj2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of KCNJ2 mRNA CTD PMID:33387578 phenethyl caffeate multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of KCNJ2 mRNA CTD PMID:20360939 phenylmercury acetate increases expression ISO KCNJ2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of KCNJ2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNJ2 mRNA CTD PMID:27188386 potassium atom multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 Barium inhibits the reaction [KCNJ2 protein results in increased transport of Potassium] CTD PMID:15958527 and PMID:17347781 potassium atom increases transport ISO KCNJ2 (Homo sapiens) 6480464 KCNJ2 protein results in increased transport of Potassium CTD PMID:12598232 more ... potassium atom increases transport ISO Kcnj2 (Rattus norvegicus) 6480464 KCNJ2 protein results in increased transport of Potassium CTD PMID:11087224 potassium atom multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 barium chloride inhibits the reaction [KCNJ2 protein results in increased transport of Potassium] CTD PMID:11087224 potassium atom increases transport EXP 6480464 KCNJ2 protein results in increased transport of Potassium CTD PMID:12118013 propranolol affects response to substance ISO KCNJ2 (Homo sapiens) 6480464 KCNJ2 gene affects the susceptibility to Propranolol CTD PMID:15028050 rotenone multiple interactions ISO Kcnj2 (Rattus norvegicus) 6480464 [3-bromo-2-oxopropionic acid co-treated with Rotenone] results in increased expression of KCNJ2 mRNA and [3-bromo-2-oxopropionic acid co-treated with Rotenone] results in increased expression of KCNJ2 protein CTD PMID:31585160 SB 431542 multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of KCNJ2 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO KCNJ2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of KCNJ2 mRNA CTD PMID:22714537 sulforaphane increases expression ISO KCNJ2 (Homo sapiens) 6480464 sulforaphane results in increased expression of KCNJ2 mRNA CTD PMID:31838189 sunitinib increases expression ISO KCNJ2 (Homo sapiens) 6480464 Sunitinib results in increased expression of KCNJ2 mRNA CTD PMID:31533062 temozolomide increases expression ISO KCNJ2 (Homo sapiens) 6480464 Temozolomide results in increased expression of KCNJ2 mRNA CTD PMID:31758290 thapsigargin increases expression ISO KCNJ2 (Homo sapiens) 6480464 Thapsigargin results in increased expression of KCNJ2 mRNA CTD PMID:22378314 thioacetamide increases expression ISO Kcnj2 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of KCNJ2 mRNA CTD PMID:34492290 tribromoethanol affects response to substance EXP 6480464 KCNJ2 affects the susceptibility to tribromoethanol CTD PMID:17546530 trichostatin A decreases expression ISO KCNJ2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of KCNJ2 mRNA CTD PMID:24935251 trichostatin A increases expression ISO KCNJ2 (Homo sapiens) 6480464 trichostatin A results in increased expression of KCNJ2 mRNA CTD PMID:24935251 triclosan increases expression ISO KCNJ2 (Homo sapiens) 6480464 Triclosan results in increased expression of KCNJ2 mRNA CTD PMID:28940058 urethane decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Urethane results in decreased expression of KCNJ2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO KCNJ2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of KCNJ2 mRNA CTD PMID:23179753 and PMID:26272509 valproic acid increases expression ISO KCNJ2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of KCNJ2 mRNA CTD PMID:28001369 valproic acid multiple interactions ISO KCNJ2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNJ2 mRNA CTD PMID:27188386 vorinostat decreases expression ISO KCNJ2 (Homo sapiens) 6480464 vorinostat results in decreased expression of KCNJ2 mRNA CTD PMID:27188386 zearalenone increases expression ISO KCNJ2 (Homo sapiens) 6480464 Zearalenone results in increased expression of KCNJ2 mRNA CTD PMID:36828454